As of 2024-07-27, the Relative Valuation of Cytosorbents Corp (CTSO) is (18.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.03 USD, the upside of Cytosorbents Corp based on Relative Valuation is -1849.7%.
The range of the Relative Valuation is (18.49) - (16.96) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 36.5x - 41.7x | 38.2x |
| Forward P/E multiples | 31.8x - 33.5x | 33.0x |
| Fair Price | (18.49) - (16.96) | (18.02) |
| Upside | -1895.5% - -1746.9% | -1849.7% |
| Date | P/E |
| 2024-07-26 | -2.03 |
| 2024-07-25 | -2.03 |
| 2024-07-24 | -1.99 |
| 2024-07-23 | -2.02 |
| 2024-07-22 | -2.07 |
| 2024-07-19 | -2.07 |
| 2024-07-18 | -2.05 |
| 2024-07-17 | -2.17 |
| 2024-07-16 | -2.21 |
| 2024-07-15 | -2.11 |
| 2024-07-12 | -2.13 |
| 2024-07-11 | -1.92 |
| 2024-07-10 | -1.95 |
| 2024-07-09 | -1.99 |
| 2024-07-08 | -1.99 |
| 2024-07-05 | -1.79 |
| 2024-07-03 | -1.70 |
| 2024-07-02 | -1.62 |
| 2024-07-01 | -1.38 |
| 2024-06-28 | -1.39 |
| 2024-06-27 | -1.52 |
| 2024-06-26 | -1.54 |
| 2024-06-25 | -1.51 |
| 2024-06-24 | -1.52 |
| 2024-06-21 | -1.58 |
| 2024-06-20 | -1.56 |
| 2024-06-18 | -1.49 |
| 2024-06-17 | -1.64 |
| 2024-06-14 | -1.66 |
| 2024-06-13 | -1.71 |
| 2024-06-12 | -1.70 |
| 2024-06-11 | -1.77 |
| 2024-06-10 | -1.76 |
| 2024-06-07 | -1.75 |
| 2024-06-06 | -1.75 |
| 2024-06-05 | -1.83 |
| 2024-06-04 | -1.75 |
| 2024-06-03 | -1.80 |
| 2024-05-31 | -1.78 |
| 2024-05-30 | -1.74 |
| 2024-05-29 | -1.78 |
| 2024-05-28 | -1.70 |
| 2024-05-24 | -1.78 |
| 2024-05-23 | -1.84 |
| 2024-05-22 | -1.85 |
| 2024-05-21 | -1.85 |
| 2024-05-20 | -1.93 |
| 2024-05-17 | -1.91 |
| 2024-05-16 | -1.71 |
| 2024-05-15 | -1.66 |